Targeting IL-5 in severe asthma: a DREAM come true?

Lancet. 2012 Aug 18;380(9842):626-7. doi: 10.1016/S0140-6736(12)61132-5.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-Asthmatic Agents / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Asthma / prevention & control*
  • Female
  • Humans
  • Male
  • Pulmonary Eosinophilia / prevention & control*

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • mepolizumab